Our Newsletters

Filter By: 
 

2012

Date Title
January 4, 2012

FDA Issues Draft Guidance, Requests Public Comments on Communication of Off-Label Information

Type: On the Subject

 

2011

Date Title
July 7, 2011

CMS Proposes to Retract New Physician Lab Signature Requirement

Type: On the Subject

 

2010

Date Title
May 24, 2010

Health Care Reform: Comparative Effectiveness Research

Type: On the Subject

May 5, 2010

Health Care Reform: Congress Creates Independent Payment Advisory Board: Are Medicare Solvency Decisions Finally on the Way?

Type: On the Subject

April 26, 2010

Health Care Reform: Patient Protection and Affordable Care Act Expands Hospital Eligibility for 340B Program

Type: On the Subject

 

2009

Date Title
April 23, 2009

Systemic Health Reform Will Occur Under Obama

Type: On the Subject

 

2008

Date Title
November 24, 2008

A Look Ahead: The 2009 U.S. Health Legislative Landscape

Type: On the Subject

October 14, 2008

A Look Ahead: the 2009 U.S. Health Legislative Agenda

Type: White Papers

October 1, 2008

FDA Challenges Implied Outcomes Claims for Several ADHD Products: An Analysis

Type: On the Subject

July 15, 2008

PhRMA Revises Code on Interactions with Healthcare Professionals

Type: White Papers

May 29, 2008

Merck Settles Vioxx® Litigation with State Attorneys General: an Analysis

Type: White Papers

April 29, 2008

FDA Issues Draft Guidance on Certification Requirements Under New Clinical Trial Registration and Posting Provisions

Type: On the Subject

 

2007

Date Title
October 15, 2007

FDA Oversight of Clinical Trials

Type: On the Subject

 

2006

Date Title
July 25, 2006

CMS Announces Reconsideration of Clinical Trial Billing Policy

Type: On the Subject

 

2002

Date Title
Summer 2002

International News, Volume 4, No. 1-2, Summer 2002

Type: International News

McDermott Will & Emery

McDermott Will and Emery